← FDA DRUG APPROVALS

FDA ANDA · ANDA065032

DOXYCYCLINE

Sponsor: SANDOZ INC

APPLICATION
ANDA065032
TYPE
ANDA
ORIGINAL APPROVAL
2000-06-30
LATEST ACTION
2002-12-23
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

DOXYCYCLINEDiscontinued
DOXYCYCLINE EQ 100MG BASE · CAPSULE · ORAL
DOXYCYCLINEDiscontinued
DOXYCYCLINE EQ 50MG BASE · CAPSULE · ORAL

Approval history

2002-12-23Labeling · Supplement 2AP
2000-12-07Manufacturing (CMC) · Supplement 1AP
2000-06-30OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →